Nucleic Acid Arrays for Early Tissue Rejection Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting tissue rejection in transplanted organs are inefficient, often requiring visible histological signs to appear before diagnosis, leading to delayed treatment and potential organ loss.
Innovation Solution
The use of nucleic acid arrays and specific transcripts, such as gamma interferon-induced transcripts (GITs) and rejection-induced transcripts (RITs), to detect early signs of tissue rejection by measuring differential expression levels in transplanted tissue compared to control tissue, allowing for timely intervention with immunosuppressants.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current methods for detecting tissue rejection are used, then diagnosis can be made when visible histological signs appear, but detection is delayed and treatment is late
Solution Approach 1:
The patent applies preliminary action by detecting rejection-induced transcripts (RITs) and gamma interferon-induced transcripts (GITs) in tissue samples before visible histological signs of rejection appear. The nucleic acid array method identifies differentially expressed nucleic acids early in the rejection process, enabling diagnosis and treatment initiation prior to clinical manifestation, thus resolving the contradiction between detection precision and time loss.
2Measurement precision
If nucleic acid arrays with multiple transcripts are used, then early detection accuracy improves, but device complexity increases
Solution Approach 1:
The patent applies the extraction principle by selecting and analyzing only specific rejection-induced transcripts (RITs) and gamma interferon-induced transcripts (GITs) from the complex array of all possible nucleic acids. The method extracts and measures the expression levels of these particular differentially expressed nucleic acids using the nucleic acid array, achieving high detection accuracy while managing device complexity through targeted selection of biomarkers.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables early detection of tissue rejection before visible signs emerge, facilitating appropriate treatment and reducing the risk of organ rejection and loss.
Implementation Method 1
nucleic acid arrays that can be used to diagnose tissue rejection in a mammal. Such arrays can allow clinicians to diagnose tissue rejection early based on a determination of the expression levels of nucleic acids that are differentially expressed in tissue being rejected as compared to control tissue not being rejected
Data Source
AI summary
This document relates to methods and materials involved in detecting tissue rejection (e.g., organ rejection). For example, this document relates to methods and materials involved in the early detection of kidney tissue rejection.